⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IMUX News

Immunic, Inc. Common Stock

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis